Skip to Main Navigation

Cambodia COVID-19 Emergency Response Project

Abstract*

The objective of the COVID-19 Emergency Response Project in Cambodia is to assist Cambodia in its efforts to prevent, detect and respond to the threat posed by COVID-19 (Coronavirus) and strengthen national systems for public health preparedness. This project consists of four components; Component one - case detection and management; Component two -medical supplies and equipment; Component three - preparedness, capacity building and training, and;...

* The project abstract is drawn from the PAD, SAR or PGD and may not accurately reflect the project's current nature

Show More

Development Objective

To assist Cambodia in its efforts to prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness.

Key Details

Project Details

  • P173815

  • Active

  • Nareth Ly

  • Kingdom of Cambodia

  • Cambodia

  • March 30, 2020

  • (as of board presentation)

    April 2, 2020

  • April 6, 2020

  • US$ 20.00 million

  • Ministry of Health Cambodia

  • East Asia and Pacific

  • 2020

  • US$ 24.65 million

  • N/A

  • May 26, 2024

  • September 30, 2025

  • No

  • BANK APPROVED

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
IDA Credit 20.00
Pandemic Emergency Financing Facility 1.15
Health Emergency Preparedness and Response Multi-Donor Trust 3.50

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment N/A
IDA Commitment 20.00
IBRD + IDA Commitment 20.00
Lending Instrument
Grant Amount 4.65
Total Project Cost** 20.00

Summary Status of World Bank Financing (US$ Millions) as of January 31, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of January 31, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)
Apr 2, 2020 IDA-65960 Loan Commitment 20,000,000.00
Apr 1, 2024 IDA-65960 Int Charges 1,312.42
Apr 1, 2024 IDA-65960 Int Charges 1,312.42
Apr 1, 2024 IDA-65960 Int Charges 67,892.75
Apr 1, 2024 IDA-65960 Int Charges 67,892.75
Jun 21, 2024 IDA-65960 Loan Disb 1,355,171.90
May 6, 2024 IDA-65960 Loan Disb -600,000.00
Oct 1, 2023 IDA-65960 Int Charges 69,450.42
Oct 1, 2023 IDA-65960 Int Charges 69,450.42
Oct 1, 2023 IDA-65960 Int Charges 334.86
Oct 1, 2023 IDA-65960 Int Charges 334.86
Oct 10, 2023 IDA-65960 Loan Disb -290,334.38
Oct 1, 2022 IDA-65960 Int Charges 941.17
Oct 1, 2022 IDA-65960 Int Charges 941.17
Oct 1, 2022 IDA-65960 Int Charges 67,181.45
Oct 1, 2022 IDA-65960 Int Charges 67,181.45
Apr 1, 2023 IDA-65960 Int Charges 68,998.97
Apr 1, 2023 IDA-65960 Int Charges 68,998.97
Apr 1, 2023 IDA-65960 Int Charges 2,388.25
Apr 1, 2023 IDA-65960 Int Charges 2,388.25
Sep 27, 2022 IDA-65960 Loan Disb -0.50
Sep 27, 2022 IDA-65960 Loan Disb -38,560.01
Feb 5, 2021 IDA-65960 Loan Disb 528,000.00
Dec 11, 2020 IDA-65960 Loan Disb 864,733.30
Oct 28, 2021 IDA-65960 Loan Disb 1,727,999.10
Oct 26, 2021 IDA-65960 Loan Disb -20,211.35
Apr 1, 2021 IDA-65960 Int Charges 336.97
Apr 1, 2021 IDA-65960 Int Charges 336.97
Jul 19, 2021 IDA-65960 Loan Disb 1,417,500.00
Aug 6, 2021 IDA-65960 Loan Disb 76,163.46
Oct 1, 2021 IDA-65960 Int Charges 387.18
Oct 1, 2021 IDA-65960 Int Charges 387.18
Oct 1, 2021 IDA-65960 Int Charges 57,494.21
Oct 1, 2021 IDA-65960 Int Charges 57,494.21
Oct 26, 2021 IDA-65960 Loan Disb -0.01
Aug 9, 2021 IDA-65960 Loan Disb 1,766,332.60
Jun 7, 2022 IDA-65960 Loan Disb -41,698.04
Apr 1, 2022 IDA-65960 Int Charges 1,265.79
Apr 1, 2022 IDA-65960 Int Charges 1,265.79
Apr 1, 2022 IDA-65960 Int Charges 72,634.53
Apr 1, 2022 IDA-65960 Int Charges 72,634.53
Sep 9, 2020 IDA-65960 Loan Disb 802,966.70
Jun 2, 2020 IDA-65960 Loan Disb 1,054,035.60
Jun 29, 2020 IDA-65960 Loan Disb 3,029,005.00
Jun 19, 2020 IDA-65960 Loan Disb 607,500.00
Oct 1, 2020 IDA-65960 Int Charges 18,240.46
May 11, 2021 IDA-65960 Loan Disb 1,782,665.90
May 11, 2021 IDA-65960 Loan Disb 685,471.25
Feb 17, 2021 IDA-65960 Loan Disb 481,893.00
Jan 13, 2021 IDA-65960 Loan Disb 161,803.62
Oct 1, 2020 IDA-65960 Int Charges 18,240.46
Jul 13, 2020 IDA-65960 Loan Disb 5,000,000.00
Apr 1, 2021 IDA-65960 Int Charges 43,143.93
Apr 1, 2021 IDA-65960 Int Charges 43,143.93

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Procurement Satisfactory 2024-12-27
Project Management Satisfactory 2024-12-27
Overall Implementation Progress (IP) Moderately Satisfactory 2024-12-27
Monitoring and Evaluation Satisfactory 2024-12-27
Progress towards achievement of PDO Satisfactory 2024-12-27
Financial Management Satisfactory 2024-12-27
Monitoring and Evaluation Satisfactory 2024-12-27
Overall Implementation Progress (IP) Moderately Satisfactory 2024-12-27
Progress towards achievement of PDO Satisfactory 2024-12-27
Procurement Satisfactory 2024-12-27
Project Management Satisfactory 2024-12-27
Financial Management Satisfactory 2024-12-27

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • Number of designated laboratories with COVID-19 diagnostic equipment, test kits, and reagentsValue1.0015.002.00
    DateMarch 19, 2020May 10, 2024December 31, 2022
    Comment
  • Number of provincial hospitals with adequate supply of PPE to manage 30 COVID-19 cases and undertake outbreak investigationsValue0.0025.0025.00
    DateMarch 19, 2020May 10, 2024December 31, 2022
    Comment
  • Number of acute healthcare facilities with isolation capacityValue0.0030.0025.00
    DateMarch 19, 2020November 30, 2023December 31, 2022
    Comment
  • Percentage of population vaccinated, which is included in the priority population groups defined in national plan.Value0.0015.0015.00
    DateMarch 1, 2021May 10, 2024December 31, 2022
    Comment
  • Percentage of population vaccinated, which is included in the priority population groups defined in national plan(Female)Value0.007.597.50
    DateMarch 1, 2021May 10, 2024December 31, 2022
    Comment
  • Percentage of population vaccinated, which is included in the priority population groups defined in national plan (Male)Value0.007.417.50
    DateMarch 1, 2021May 10, 2024December 31, 2022
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • Percentage of complaints to the Grievance Redress Mechanism (GRM) satisfactorily addressed within 15 weeks of initial complaint being recordedValue0.000.0080.00
    DateMarch 19, 2020May 10, 2024December 31, 2022
    Comment
  • Standard design for provincial hospital isolation and treatment centers is finalizedValueNoYesYes
    DateMarch 19, 2020May 10, 2024December 31, 2024
    Comment
  • Daily capacity of NIPH in conducting COVID-19 or similar testsValue100.006000.00400.00
    DateMarch 19, 2020May 10, 2024December 31, 2022
    Comment
  • Percentage of EOCs functioning at national, province and district levelValue0.00100.0080.00
    DateMarch 19, 2020May 10, 2024December 31, 2022
    Comment
  • Message and material developed to build awareness in the event of a pandemic infectious disease outbreakValueNoYesYes
    DateMarch 19, 2020May 10, 2024December 31, 2022
    Comment
  • Number of provincial hospitals with functioning isolation and treatment centersValue0.0025.0025.00
    DateMarch 19, 2020May 10, 2024December 31, 2022
    Comment
  • Number of laboratories at provincial referral hospitals equipped per national guidelineValue0.0025.0025.00
    DateMarch 19, 2020May 10, 2024December 31, 2022
    Comment
  • Percentage of healthcare workers trained in clinical management/infection prevention and controlValue0.00100.0080.00
    DateMarch 19, 2020May 10, 2024December 31, 2022
    Comment
  • Number of bio-safety level 2+ laboratory established at regional laboratoryValue0.002.002.00
    DateJuly 15, 2020May 10, 2024December 31, 2022
    Comment
  • Percentage of healthcare workers trained in surveillance and investigationValue0.0088.0080.00
    DateMarch 19, 2020May 10, 2024December 31, 2022
    Comment
  • Number of call centers established and functioningValue10.00128.00100.00
    DateMarch 19, 2020May 10, 2024December 31, 2022
    Comment
  • Number of health facilities at the provincial level having cold chain facilities prior to receipt of vaccineValue0.0010.0010.00
    DateMarch 1, 2021May 10, 2024December 31, 2022
    Comment
  • Number of bio-safety level 3 lab establishedValue1.001.002.00
    DateMarch 19, 2020May 10, 2024December 31, 2024
    Comment
  • Percentage of operational districts having micro-plans in place before vaccines are deliveredValue0.00100.00100.00
    DateMarch 1, 2021May 10, 2024December 31, 2022
    Comment
  • Percentage of people in target groups registered before vaccination rollout begins, disaggregated by genderValue0.00100.0017.00
    DateMarch 1, 2021May 10, 2024December 31, 2022
    Comment
  • Percentage of people in target groups registered before vaccination rollout begins (female)Value0.0051.108.50
    DateMarch 1, 2021May 10, 2024December 31, 2022
    Comment
  • Percentage of people in target groups registered before vaccination rollout begins (male)Value0.0048.908.50
    DateMarch 1, 2021May 10, 2024December 31, 2022
    Comment